Occudo Quantitative Strategies LP Biomarin Pharmaceutical Inc Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $552,897 - $671,784	7,735 Added 134.69%	13,478 $1.12 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $426,590 - $532,318	5,743 New	5,743 $443,000
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $214,729 - $273,861	-2,994 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $223,861 - $255,897	2,994 New	2,994 $231,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $462,045 - $518,830	-6,119 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $457,272 - $554,932	6,119 New	6,119 $462,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.